Humana

Humana (HUM) Stock

US health insurer with Medicare Advantage and care services. Here's the price, business snapshot, and what's worth knowing about Humana in July 2026.

Humana Inc (HUM) is a major US health insurance and services company, best known for its large Medicare Advantage business alongside commercial and Medicaid plans. With a market cap around $35.5bn, Humana generates revenues from premiums, care-management services and health-services initiatives that aim to lower costs and improve outcomes. Investors often watch Humana for its exposure to the growing Medicare Advantage market and its push into value-based care, primary-care partnerships and home health services, which can offer structural growth if executed well. Key considerations include reimbursement policy, regulatory oversight, medical-cost trends and membership retention. The stock can be sensitive to election-driven healthcare policy and short-term claims volatility. This summary is educational and not personalised investment advice; returns are not guaranteed and the value of investments can fall as well as rise. Consider your goals, risk tolerance and seek independent advice before investing.

Why It’s Moving

Humana

Healthcare Sector Momentum and Analyst Optimism Fuel Humana's Projected 55% Upside for 2026", "summary": "Investors are reacting to a broader shift in the healthcare sector where analysts are revising long-term valuations for major insurers based on improved regulatory clarity and steady membership growth. The market interprets these consensus upgrades as a signal that Humana is poised to capitalize on emerging efficiency trends and cost-control measures over the next year.", "bullets": [ "Analysts have highlighted Humana's ability to outpace market expectations through advanced operational efficiency, signaling strong demand for its managed care models. ", "Recent consensus revisions among Wall Street research teams point to a 'Hold' rating that reflects stable fundamentals, with price targets ranging significantly to capture potential upside volatility. ", "The sector-wide trend of positive membership retention and steady revenue beat expectations, reinforcing the narrative that large insurers like Humana are effectively navigating current macroeconomic pressures. " ], "sentiment_tag": "Bullish"}

Investors are reacting to a broader shift in the healthcare sector where analysts are revising long-term valuations for major insurers based on improved regulatory clarity and steady membership growth. The market interprets these consensus upgrades as a signal that Humana is poised to capitalize on emerging efficiency trends and cost-control measures over the next year.
Sentiment:
🐃Bullish
  • Analysts have highlighted Humana's ability to outpace market expectations through advanced operational efficiency, signaling strong demand for its managed care models.
  • Recent consensus revisions among Wall Street research teams point to a 'Hold' rating that reflects stable fundamentals, with price targets ranging significantly to capture potential upside volatility.
  • The sector-wide trend of positive membership retention and steady revenue beat expectations, reinforcing the narrative that large insurers like Humana are effectively navigating current macroeconomic pressures.

When is the next earnings date for Humana (HUM)?

The next earnings date for Humana (HUM) is expected to be Wednesday, July 29, 2026, before the market opens, based on the company's historical reporting schedule. This report will cover the financial results for the second quarter of 2026 (Q2 2026). Analysts will use this data to update their consensus estimates, though specific price targets and upside projections are not part of this factual update. As always, investors should rely on official company filings for the most accurate and timely financial information.

Stock Performance Snapshot

Hold

Analyst Rating

Analysts suggest keeping Humana's stock as is, with a target price indicating a possible decline.

Above Average

Financial Health

Humana is performing well with strong revenue and cash flow, indicating solid financial stability.

Below Average

Dividend

Humana's dividend yield of 0.89% is below average, indicating limited dividend payout potential. If you invested $1000 you would be paid $8.90 a year in dividends (based on the last 12 months).

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Discover More Opportunities

CHE

CHEMED CORP

Provides hospice and palliative care services to patients facing life-limiting illness

ALHC

ALIGNMENT HEALTHCARE INC

Alignment Healthcare, Inc. is a consumer-centric platform designed to improve the healthcare experience for seniors. The Company’s operations primarily consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. It partners with local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology (AVA). AVA’s capabilities include consumer experience, internal care delivery, external providers, health plan operations and growth operations. AVA offers a digital ecosystem that enables its members and their support system to get the information and care they need, when and how they need it. With their AVA-powered member portal and mobile app, seniors have many self-service capabilities and can get 24/7 care, send secure messages to their concierge and care teams, check their rewards and ACCESS On-Demand Concierge Card balance, and view their health history.

BKD

Brookdale

A leading owner and operator of senior living communities in the United States.

Baskets Featuring HUM

Medicare Advantage Rate Hike Opportunities in 2026

Medicare Advantage Rate Hike Opportunities in 2026

The Centers for Medicare & Medicaid Services finalized a 2.48% payment increase for 2027, granting health insurers a surprise $13 billion funding boost. This collection features managed care organizations and healthcare providers poised to benefit from this highly favorable regulatory reversal.

Published: 10 April 2026

Explore Basket
Job Growth Surge: Which Industries Could Capitalise?

Job Growth Surge: Which Industries Could Capitalise?

ADP reported that the private sector added 62,000 jobs in March, beating expectations and highlighting strong wage gains for job-changers. This steady labor market resilience presents a compelling investment case for healthcare providers, educational services, and human capital management firms.

Published: 2 April 2026

Explore Basket
Regulatory Relief Stocks | FTC Court Ruling Impact

Regulatory Relief Stocks | FTC Court Ruling Impact

A federal appeals court has overturned an FTC order against Intuit, significantly limiting the agency's ability to use internal judges. This precedent forces regulators to face higher burdens of proof in federal court, providing potential relief to corporations fighting administrative overreach.

Published: 21 March 2026

Explore Basket
Defensive Equities | Risks in a Slowing Labour Market

Defensive Equities | Risks in a Slowing Labour Market

After the U.S. economy unexpectedly shed 92,000 jobs in February, investors are seeking shelter from the resulting market volatility. This collection features resilient, non-cyclical companies that historically maintain their value and offer stability during periods of economic deceleration.

Published: 9 March 2026

Explore Basket
US Jobs Surge | Healthcare & Construction Stocks

US Jobs Surge | Healthcare & Construction Stocks

The U.S. labor market showed surprising strength in January, adding far more jobs than anticipated, led by the healthcare and construction industries. This theme focuses on the companies benefiting from this robust and targeted hiring, signaling a potential expansion in these key sectors.

Published: 12 February 2026

Explore Basket
Medicare Cost Stocks (UNH, CVS) May Benefit

Medicare Cost Stocks (UNH, CVS) May Benefit

The U.S. government's successful negotiation of lower prices for key Medicare drugs signals a major shift in pharmaceutical pricing power. This creates a potential investment opportunity in managed care and healthcare service companies poised to benefit from the system's increased focus on cost efficiency.

Published: 26 November 2025

Explore Basket
Dow 48,000 Rally: Bull Market Risks & Opportunities

Dow 48,000 Rally: Bull Market Risks & Opportunities

The Dow Jones Industrial Average has surpassed 48,000 for the first time, driven by strong performance in the healthcare and financial sectors. This milestone suggests a bullish outlook on the U.S. economy, creating opportunities among the leading blue-chip companies.

Published: 14 November 2025

Explore Basket
Dow Record Rally: What's Next for Value Stocks?

Dow Record Rally: What's Next for Value Stocks?

The Dow Jones Industrial Average reached a historic high, closing above 48,000, fueled by the end of a government shutdown and a market rotation into value stocks. This shift suggests an investment opportunity in the outperforming healthcare and financial sectors, which are leading the charge.

Published: 13 November 2025

Explore Basket
Government Shutdown Impact: Defensive Stocks Explained

Government Shutdown Impact: Defensive Stocks Explained

A U.S. government shutdown has been triggered by a congressional budget impasse, creating economic uncertainty. This theme focuses on companies in defensive sectors that may prove resilient to the resulting market volatility and disruptions in federal spending.

Published: 2 October 2025

Explore Basket
At-Home Healthcare Stocks Explained | FDA Approval

At-Home Healthcare Stocks Explained | FDA Approval

The FDA's approval of an injectable, at-home version of Eisai and Biogen's Alzheimer's drug simplifies treatment and reduces the need for hospital visits. This development highlights a broader trend toward at-home care, creating potential investment opportunities in companies that provide related medical devices and healthcare services.

Published: 30 August 2025

Explore Basket
Defensive Plays Amid Fed Turmoil

Defensive Plays Amid Fed Turmoil

The removal of a Federal Reserve governor has created political and financial uncertainty, shaking confidence in the central bank's stability. This environment could create opportunities for investments in defensive sectors and assets that are traditionally seen as safe havens during periods of market volatility.

Published: 26 August 2025

Explore Basket
Following Buffett's Healthcare Bet

Following Buffett's Healthcare Bet

Warren Buffett's Berkshire Hathaway is making a major $2.1 billion bet on UnitedHealth, signaling a strategic shift toward the healthcare sector. This theme focuses on other health insurers and healthcare providers that could benefit from this renewed investor confidence.

Published: 15 August 2025

Explore Basket
Healthcare In The Crosshairs: Insurers Under Scrutiny

Healthcare In The Crosshairs: Insurers Under Scrutiny

The Department of Justice is investigating UnitedHealth Group's Medicare billing, creating uncertainty for the nation's largest insurer. This situation presents a potential opportunity for rival health insurers to gain market share and for compliance-focused companies that help the industry navigate complex regulations.

Published: 25 July 2025

Explore Basket
Healthcare Billing Integrity

Healthcare Billing Integrity

This group of stocks includes companies positioned to benefit from increased focus on healthcare billing compliance. Carefully selected by professional analysts, these stocks represent both healthcare tech providers offering compliance solutions and competing insurers who may gain market share amid regulatory scrutiny.

Published: 11 July 2025

Explore Basket
Medicaid Politics

Medicaid Politics

Discover companies whose fortunes are closely tied to government healthcare funding decisions. These carefully selected stocks represent businesses with significant exposure to Medicaid, now facing heightened legislative uncertainty after Senator Tillis's retirement.

Published: 30 June 2025

Explore Basket

Why You’ll Want to Watch This Stock

📈

Medicare Advantage Focus

Humana’s scale in Medicare Advantage can be a structural growth engine, though outcomes depend on policy and medical-cost trends.

Care-Delivery Push

Investors may watch its moves into value-based care and home health since these can improve margins over time, but execution risk remains.

🌍

Regulatory Sensitivity

Policy and reimbursement changes materially affect profits and membership; consider regulatory risk alongside growth opportunities.

Why invest with Nemo?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions